Ing Groep Nv Senseonics Holdings, Inc. Transaction History

Ing Groep Nv

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$1.81 - $2.45 $528,614 - $715,527	-292,052 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$2.49 - $4.54 $15,271 - $27,843	-6,133 Reduced 2.06%	292,052 $756,000
Q3 2018 Nov 06, 2018	BUY	$3.4 - $4.84 $13,600 - $19,360	4,000 Added 1.36%	298,185 $1.42 Million
Q2 2018 Aug 10, 2018	BUY	$3.03 - $4.98 $146,046 - $240,036	48,200 Added 19.59%	294,185 $1.21 Million
Q1 2018 May 07, 2018	BUY	$2.48 - $3.21 $25,732 - $33,306	10,376 Added 4.4%	245,985 $738,000
Q4 2017 Feb 06, 2018	BUY	$2.43 - $3.54 $23,755 - $34,607	9,776 Added 4.33%	235,609 $627,000
Q3 2017 Nov 08, 2017	BUY	$2.22 - $3.2 $501,349 - $722,665	225,833	225,833 $720,000

140

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $363M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.